Fundraising Fox

Quarry Thera

New Haven, US · Founded 2024 · Delaware LLC · 23 employees on LinkedIn · 5 known investors

Quarry Thera is a biotech developing oral small-molecule medicines based on induced-proximity pharmacology, using molecular glues and heterobifunctional compounds. It applies two proprietary proximity technologies (SIDTAGs and TISSTAGs) to target biology in immunology and oncology.

BiotechDeep Tech

Founders & leadership

Quarry Thera was founded in 2024 by Craig Crews.

CCCraig Crews
Craig CrewsinCo-Founder & Scientific Advisor
DM
Dan McHughManager
TSTim Shannon
Tim Shannonin𝕏CEO and Board MemberGeneral Partner at Canaan Partners
JMJeanne Magram
Jeanne MagraminChief Scientific Officer
KRKanak Raina
Kanak RainaChief Technology Officer
SCSean Cassidy
Sean CassidyinChief Financial Officer

Board

MDMikael Dolsten
Mikael DolsteninExecutive Chair

Investors · 5

Yosemite✓ verifiedSan Francisco
F-Prime CapitalCambridge · $3M – $10M
Canaan Partnersreported · 2 sourcesStamford · $500K – $20M
Lilly Venturesreported · 2 sources

Also in the syndicate · 1

Eli Lilly

Funding

SEC filings, press & company announcements

$37M disclosed across 2 of 3 rounds · 2025–2026

▶$5MraisedFeb 2025 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dan McHughDirector
  • Craig CrewsExecutive Officer, Director
  • Mikael DolstenDirector
Offering amount
$5M
Amount sold
$5M
First sale
Feb 2025
Incorporated
Limited Liability Company, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Preqin3 shared keywordsPreqin provides private markets data, analytics, and benchmarking across private equity, venture capital, hedge funds, real estate, private credit, infrastructure, secondaries, and natural resources. Its products serve fund managers, investors, consultants, banks, and other financial professionals for fundraising, manager selection, due diligence, and performance analysis.

Companies competing with Quarry Thera for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Top 10 Pharma Drug Discovery Delivery Capital Raises and Investors in the U.S. - November 16th - December 31st, 2025castleplacement.com · Jan 2026Induced Proximity Company Quarry Thera Debuts with USD 32m Fundingglobal.pharmcube.com · Nov 2025Rx Rundown: Novo Nordisk, Mayne Pharma, Quarry Thera and moremmm-online.com · Nov 2025Quarry Thera Secures $32M Series A Fundingleadsontrees.com · Nov 2025Trysignalbasetrysignalbase.com · Nov 2025Biotech & Pharma Updates | October 22 - 23, 2025tldrbio.tech · Oct 2025

Frequently asked questions

What does Quarry Thera do?
Quarry Thera is a biotech developing oral small-molecule medicines based on induced-proximity pharmacology, using molecular glues and heterobifunctional compounds. It applies two proprietary proximity technologies (SIDTAGs and TISSTAGs) to target biology in immunology and oncology.
Who founded Quarry Thera?
Quarry Thera was founded by Craig Crews in 2024.
Who are Quarry Thera's investors?
Quarry Thera's investors include Yosemite, F-Prime Capital, Canaan Partners, Lilly Ventures.
How much funding has Quarry Thera raised?
Quarry Thera has disclosed $37M raised across 2 of its 3 known rounds.
Where is Quarry Thera headquartered?
Quarry Thera is headquartered in New Haven, US.